This is the first prospective study to use an ARM data mining approach to characterize progressive disease within 3 years from diagnosis in GEP‐NET patients, including 92 cancer‐related plasma proteins, including CgA and clinical characteristics at the time of diagnosis, before NET‐specific treatment intervention. The gene discussed is CGA; the disease is cancer.